R&D Sponsored EDI in clinical research: The case for adaptive strategies a... The topic of Equality, Diversity, and Inclusion (EDI) in health and care research participation has been gaining traction in the past few years.
Market Access Sponsored NCVR: What's the true price of negotiation? A country’s ability to open trials quickly is a key consideration for commercial sponsors planning programmes of research globally.
Patients From participants to partners: The evolution of active patie... Recruitment numbers are the backbone of clinical research.
R&D Sponsored Revolutionising research: Inside the NCVR evolution in the U... On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.